Suppression of anti-cancer immunity by regulatory T cells: Back to the future

Seminars in Cancer Biology

Volumn 16, Issue 2, 2006, Pages 137-149

  Orentas, Rimas J ^a   Kohler, M Eric ^a   Johnson, Bryon D ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Cancer immunity; Regulatory T cell; Suppressor T cell

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA;

ANTINEOPLASTIC ACTIVITY; CANCER GROWTH; CANCER INHIBITION; IMMUNOREGULATION; REGULATORY T LYMPHOCYTE; REVIEW; SUPPRESSOR CELL; TUMOR IMMUNITY;

ANTIGENS, CD4; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSION; NEOPLASMS; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES, REGULATORY;

EID: 31644451518     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcancer.2005.11.007     Document Type: Review

References (126)

1. R.K. Gershon A disquisition on suppressor T cells Transplant Rev 26 1975 170 185
2. T. Umiel, and N. Trainin Immunological enhancement of tumor growth by syngeneic thymus-derived lymphocytes Transplantation 18 3 1974 244 250
3. D. Berd, and M.J. Mastrangelo Active immunotherapy of human melanoma exploiting the immunopotentiating effects of cyclophosphamide Cancer Invest 6 3 1988 337 349
4. M.S. Mitchell, R.A. Kempf, W. Harel, H. Shau, W.D. Boswell, and S. Lind Low-dose cyclophosphamide and low-dose interleukin-2 for malignant melanoma Bull NY Acad Med 65 1 1989 128 144
5. D.M. Sahasrabudhe, J.B. deKernion, J.E. Pontes, D.M. Ryan, R.W. O'Donnell, and D.M. Marquis Specific immunotherapy with suppressor function inhibition for metastatic renal cell carcinoma J Biol Response Mod 5 6 1986 581 594
6. B. Mukherji, A.L. Nashed, A. Guha, and M.T. Ergin Regulation of cellular immune response against autologous human melanoma. II. Mechanism of induction and specificity of suppression J Immunol 136 5 1986 1893 1898
7. B. Mukherji, S.A. Wilhelm, A. Guha, and M.T. Ergin Regulation of cellular immune response against autologous human melanoma. I. Evidence for cell-mediated suppression of in vitro cytotoxic immune response J Immunol 136 5 1986 1888 1892
8. G. Moller Do suppressor T cells exist? Scand J Immunol 27 3 1988 247 250
9. S. Sakaguchi, N. Sakaguchi, M. Asano, M. Itoh, and M. Toda Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases J Immunol 155 3 1995 1151 1164
10. L.A. Stephens, and D. Mason CD25 is a marker for CD4+ thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25+ and CD25- subpopulations J Immunol 165 6 2000 3105 3110
11. C. Baecher-Allan, J.A. Brown, G.J. Freeman, and D.A. Hafler CD4+CD25high regulatory cells in human peripheral blood J Immunol 167 3 2001 1245 1253
12. H. Jonuleit, E. Schmitt, M. Stassen, A. Tuettenberg, J. Knop, and A.H. Enk Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood J Exp Med 193 11 2001 1285 1294
13. M.K. Levings, R. Sangregorio, and M.G. Roncarolo Human CD25(+)CD4(+) T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function J Exp Med 193 11 2001 1295 1302
14. W.F. Ng, P.J. Duggan, F. Ponchel, G. Matarese, G. Lombardi, and A.D. Edwards Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells Blood 98 9 2001 2736 2744
15. L.A. Stephens, C. Mottet, D. Mason, and F. Powrie Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro Eur J Immunol 31 4 2001 1247 1254
16. S. Sakaguchi Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses Annu Rev Immunol 22 2004 531 562
17. R. Khattri, T. Cox, S.A. Yasayko, and F. Ramsdell An essential role for Scurfin in CD4+CD25+ T regulatory cells Nat Immunol 4 4 2003 337 342
18. S. Hori, T. Nomura, and S. Sakaguchi Control of regulatory T cell development by the transcription factor Foxp3 Science 299 5609 2003 1057 1061
19. J.D. Fontenot, M.A. Gavin, and A.Y. Rudensky Foxp3 programs the development and function of CD4+CD25+ regulatory T cells Nat Immunol 4 4 2003 330 336
20. K.J. Maloy, F. Powrie, and Regulatory T cells in the control of immune pathology Nat Immunol 2 9 2001 816 822
21. K.H. Mills, and Regulatory T cells: friend or foe in immunity to infection? Nat Rev Immunol 4 11 2004 841 855
22. V. Rotter, and N. Trainin Elimination of suppressor T cells in mice undergoing a graft-versus-host reaction expressed by increased response to polyvinylpyrrolidone (PVP) Cell Immunol 18 1 1975 199 209
23. J.O. Hill, M. Awwad, and R.J. North Elimination of CD4+ suppressor T cells from susceptible BALB/c mice releases CD8+ T lymphocytes to mediate protective immunity against Leishmania J Exp Med 169 5 1989 1819 1827
24. M. Awwad, and R.J. North Cyclophosphamide-induced immunologically mediated regression of a cyclophosphamide-resistant murine tumor: a consequence of eliminating precursor L3T4+ suppressor T cells Cancer Res 49 7 1989 1649 1654
25. M. Awwad, and R.J. North Cyclophosphamide (Cy)-facilitated adoptive immunotherapy of a Cy-resistant tumour. Evidence that Cy permits the expression of adoptive T cell-mediated immunity by removing suppressor T cells rather than by reducing tumour burden Immunology 65 1 1988 87 92
26. M. Awwad, and R.J. North Sublethal, whole-body ionizing irradiation can be tumor promotive or tumor destructive depending on the stage of development of underlying antitumor immunity Cancer Immunol Immunother 26 1 1988 55 60
27. M. Awwad, and R.J. North Immunologically mediated regression of a murine lymphoma after treatment with anti-L3T4 antibody. A consequence of removing L3T4+ suppressor T cells from a host generating predominantly Lyt-2+ T cell-mediated immunity J Exp Med 168 6 1988 2193 2206
28. R.J. North Radiation-induced, immunologically mediated regression of an established tumor as an example of successful therapeutic immunomanipulation. Preferential elimination of suppressor T cells allows sustained production of effector T cells J Exp Med 164 5 1986 1652 1666
29. R.J. North Dye ES. Ly 1+2- suppressor T cells down-regulate the generation of Ly 1-2+ effector T cells during progressive growth of the P815 mastocytoma Immunology 54 1 1985 47 56
30. R.J. North, and I. Bursuker Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells J Exp Med 159 5 1984 1295 1311
31. E.S. Dye, and R.J. North T cell-mediated immunosuppression as an obstacle to adoptive immunotherapy of the P815 mastocytoma and its metastases J Exp Med 154 4 1981 1033 1042
32. M.J. Berendt, and R.J. North T cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor J Exp Med 151 1 1980 69 80
33. E. Gorelik Concomitant tumor immunity and the resistance to a second tumor challenge Adv Cancer Res 39 1983 71 120
34. H.D. Bear Tumor-specific suppressor T cells which inhibit the in vitro generation of cytolytic T cells from immune and early tumor-bearing host spleens Cancer Res 46 4 Pt 1 1986 1805 1812
35. M. Awwad, and R.J. North Radiosensitive barrier to T cell-mediated adoptive immunotherapy of established tumors Cancer Res 50 8 1990 2228 2233
36. R.J. North, and M. Awwad Elimination of cycling CD4+ suppressor T cells with an anti-mitotic drug releases non-cycling CD8+ T cells to cause regression of an advanced lymphoma Immunology 71 1 1990 90 95
37. A.L. Rakhmilevich, R.J. North, and E.S. Dye Presence of CD4+ T suppressor cells in mice rendered unresponsive to tumor antigens by intravenous injection of irradiated tumor cells Int J Cancer 55 2 1993 338 343
38. K.E. Hellstrom, I. Hellstrom, J.A. Kant, and J.D. Tamerius Regression and inhibition of sarcoma growth by interference with a radiosensitive T cell population J Exp Med 148 3 1978 799 804
39. R.J. North Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells J Exp Med 155 4 1982 1063 1074
40. M.E. Dudley, J.R. Wunderlich, J.C. Yang, R.M. Sherry, S.L. Topalian, and N.P. Restifo Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma J Clin Oncol 23 10 2005 2346 2357
41. N.G. Chakraborty, D.R. Twardzik, M. Sivanandham, M.T. Ergin, K.E. Hellstrom, and B. Mukherji Autologous melanoma-induced activation of regulatory T cells that suppress cytotoxic response J Immunol 145 7 1990 2359 2564
42. B. Mukherji, A. Guha, N.G. Chakraborty, M. Sivanandham, A.L. Nashed, and J.R. Sporn Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma J Exp Med 169 6 1989 1961 1976
43. B. Mukherji, A. Guha, R. Loomis, and M.T. Ergin Cell-mediated amplification and down regulation of cytotoxic immune response against autologous human cancer J Immunol 138 6 1987 1987 1991
44. B. Mukherji, M.T. Ergin, A. Guha, R.T. Tatake, and A.L. Nashed Suppressor cell activities in autologous human tumor systems. Suppression of tumor immunity Arch Surg 121 12 1986 1404 1408
45. S. Onizuka, I. Tawara, J. Shimizu, S. Sakaguchi, T. Fujita, and E. Nakayama Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody Cancer Res 59 13 1999 3128 3133
46. J. Shimizu, S. Yamazaki, and S. Sakaguchi Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity J Immunol 163 10 1999 5211 5218
47. D. Golgher, E. Jones, F. Powrie, T. Elliott, and A. Gallimore Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigens Eur J Immunol 32 11 2002 3267 3275
48. N. Casares, L. Arribillaga, P. Sarobe, and J. Dotor Lopez-Diaz de Cerio A, Melero I, et al. CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination J Immunol 171 11 2003 5931 5939
49. J. Li, P. Hu, L.A. Khawli, and A.L. Epstein Complete regression of experimental solid tumors by combination LEC/chTNT-3 immunotherapy and CD25(+) T cell depletion Cancer Res 63 23 2003 8384 8392
50. M.L. Chen, M.J. Pittet, L. Gorelik, R.A. Flavell, R Weissleder, and H von Boehmer Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo Proc. Natl. Acad Sci. USA 102 2 2005 419 424
51. C. Kudo-Saito, J. Schlom, K. Camphausen, C.N. Coleman, and J.W. Hodge The requirement of multimodal therapy (vaccine, local tumor radiation, and reduction of suppressor cells) to eliminate established tumors Clin Cancer Res 11 12 2005 4533 4544
52. F. Ghiringhelli, N. Larmonier, E. Schmitt, A. Parcellier, D. Cathelin, and C. Garrido CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative Eur J Immunol 34 2 2004 336 344
53. J.P. Machiels, R.T. Reilly, L.A. Emens, A.M. Ercolini, R.Y. Lei, and D. Weintraub Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice Cancer Res 61 9 2001 3689 3697
54. A.M. Ercolini, B.H. Ladle, E.A. Manning, L.W. Pfannenstiel, T.D. Armstrong, and J.P. Machiels Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response J Exp Med 201 10 2005 1591 1602
55. M.E. Lutsiak, R.T. Semnani, R. De Pascalis, S.V. Kashmiri, J. Schlom, and H. Sabzevari Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide Blood 105 7 2005 2862 2868
56. P.A. Antony, and N.P. Restifo CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2 J Immunother 28 2 2005 120 128
57. E. Jones, M. Dahm-Vicker, A.K. Simon, A. Green, F. Powrie, and V. Cerundolo Depletion of CD25+ regulatory cells results in suppression of melanoma growth and induction of autoreactivity in mice Cancer Immun 2 2002 1
58. H. Nagai, T. Horikawa, I. Hara, A. Fukunaga, S. Oniki, and M. Oka In vivo elimination of CD25+ regulatory T cells leads to tumor rejection of B16F10 melanoma, when combined with interleukin-12 gene transfer Exp Dermatol 13 10 2004 613 620
59. S.J. Prasad, K.J. Farrand, S.A. Matthews, J.H. Chang, R.S. McHugh, and F. Ronchese Dendritic cells loaded with stressed tumor cells elicit long-lasting protective tumor immunity in mice depleted of CD4+CD25+ regulatory T cells J Immunol 174 1 2005 90 98
60. J. Steitz, J. Bruck, J. Lenz, J. Knop, and T. Tuting Depletion of CD25(+) CD4(+) T cells and treatment with tyrosinase-related protein 2-transduced dendritic cells enhance the interferon alpha-induced, CD8(+) T cell-dependent immune defense of B16 melanoma Cancer Res 61 24 2001 8643 8646
61. R.P. Sutmuller, L.M. van Duivenvoorde, A. van Elsas, T.N. Schumacher, M.E. Wildenberg, and J.P. Allison Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses J Exp Med 194 6 2001 823 832
62. M.J. Turk, J.A. Guevara-Patino, G.A. Rizzuto, M.E. Engelhorn, S. Sakaguchi, and A.N. Houghton Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells J Exp Med 200 6 2004 771 782
63. A. DiGiacomo, and R.J. North T cell suppressors of antitumor immunity. The production of Ly-1-,2+ suppressors of delayed sensitivity precedes the production of suppressors of protective immunity J Exp Med 164 4 1986 1179 1192
64. S. Read, V. Malmstrom, and F. Powrie Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation J Exp Med 192 2 2000 295 302
65. T. Takahashi, T. Tagami, S. Yamazaki, T. Uede, J. Shimizu, and N. Sakaguchi Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4 J Exp Med 192 2 2000 303 310
66. D.R. Leach, M.F. Krummel, and J.P. Allison Enhancement of antitumor immunity by CTLA-4 blockade Science 271 5256 1996 1734 1736
67. L. Fong, and E.G. Engleman Dendritic cells in cancer immunotherapy Annu Rev Immunol 18 2000 245 273
68. S. Yamazaki, T. Iyoda, K. Tarbell, K. Olson, K. Velinzon, and K. Inaba Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells J Exp Med 198 2 2003 235 247
69. H. Nishikawa, T. Kato, K. Tanida, A. Hiasa, I. Tawara, and H. Ikeda CD4+ CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responses Proc Natl Acad Sci USA 100 19 2003 10902 10906
70. H. Nishikawa, T. Kato, I. Tawara, T. Takemitsu, K. Saito, and L. Wang Accelerated chemically induced tumor development mediated by CD4+CD25+ regulatory T cells in wild-type hosts Proc. Natl. Acad Sci. USA 102 26 2005 9253 9257
71. M. Nicholl, A. Lodge, I. Brown, and S.L. Sugg Restored immune response to an MHC-II-Restricted antigen in tumor-bearing hosts after elimination of regulatory T cells J Pediatr Surg 39 6 2004 941 946 discussion 41-6
72. P. Yu, Y. Lee, W. Liu, T. Krausz, A. Chong, and H. Schreiber Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors J Exp Med 201 5 2005 779 791
73. E.Y. Woo, C.S. Chu, T.J. Goletz, K. Schlienger, H. Yeh, and G. Coukos Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer Cancer Res 61 12 2001 4766 4772
74. E.Y. Woo, H. Yeh, C.S. Chu, K. Schlienger, R.G. Carroll, and J.L. Riley Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation J Immunol 168 9 2002 4272 4276
75. M. Viguier, F. Lemaitre, O. Verola, M.S. Cho, G. Gorochov, and L. Dubertret Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells J Immunol 173 2 2004 1444 1453
76. C.L. Berger, R. Tigelaar, J. Cohen, K. Mariwalla, J. Trinh, and N. Wang Cutaneous T cell lymphoma: malignant proliferation of T-regulatory cells Blood 105 4 2005 1640 1647
77. K. Karube, K. Ohshima, T. Tsuchiya, T. Yamaguchi, R. Kawano, and J. Suzumiya Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells, in adult T cell leukaemia/lymphoma cells Br J Haematol 126 1 2004 81 84
78. N.A. Marshall, L.E. Christie, L.R. Munro, D.J. Culligan, P.W. Johnston, and R.N. Barker Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma Blood 103 5 2004 1755 1762
79. B.C. Sheu, R.H. Lin, H.C. Lien, H.N. Ho, S.M. Hsu, and S.C. Huang Predominant Th2/Tc2 polarity of tumor-infiltrating lymphocytes in human cervical cancer J Immunol 167 5 2001 2972 2978
80. J. Schmidt, S. Eisold, M.W. Buchler, and A. Marten Dendritic cells reduce number and function of CD4+CD25+ cells in cytokine-induced killer cells derived from patients with pancreatic carcinoma Cancer Immunol Immunother 53 11 2004 1018 1026
81. T. Sasada, M. Kimura, Y. Yoshida, M. Kanai, and A. Takabayashi CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression Cancer 98 5 2003 1089 1099
82. H. Kawaida, K. Kono, A. Takahashi, H. Sugai, K. Mimura, and N. Miyagawa Distribution of CD4+CD25high regulatory T cells in tumor-draining lymph nodes in patients with gastric cancer J Surg Res 124 1 2005 151 157
83. A.M. Wolf, D. Wolf, M. Steurer, G. Gastl, E. Gunsilius, and B. Grubeck-Loebenstein Increase of regulatory T cells in the peripheral blood of cancer patients Clin Cancer Res 9 2 2003 606 612
84. R. Somasundaram, L. Jacob, R. Swoboda, L. Caputo, H. Song, and S. Basak Inhibition of cytolytic T lymphocyte proliferation by autologous CD4+/CD25+ regulatory T cells in a colorectal carcinoma patient is mediated by transforming growth factor-beta Cancer Res 62 18 2002 5267 5272
85. U.K. Liyanage, T.T. Moore, H.G. Joo, Y. Tanaka, V. Herrmann, and G. Doherty Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma J Immunol 169 5 2002 2756 2761
86. C. Schaefer, G.G. Kim, A. Albers, K. Hoermann, E.N. Myers, and T.L. Whiteside Characteristics of CD4+CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer Br J Cancer 92 5 2005 913 920
87. K. Sakakura, K. Chikamatsu, K. Takahashi, T.L. Whiteside, and N. Furuya Maturation of circulating dendritic cells and imbalance of T cell subsets in patients with squamous cell carcinoma of the head and neck Cancer Immunol Immunother 2005
88. C.P. Gray, P. Arosio, and P. Hersey Association of increased levels of heavy-chain ferritin with increased CD4+ CD25+ regulatory T cell levels in patients with melanoma Clin Cancer Res 9 7 2003 2551 2559
89. G.Q. Phan, J.C. Yang, R.M. Sherry, P. Hwu, S.L. Topalian, and D.J. Schwartzentruber Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma Proc Natl Acad Sci USA 100 14 2003 8372 8377
90. K.S. Voo, G. Peng, Z. Guo, T. Fu, Y. Li, and L. Frappier Functional characterization of EBV-encoded nuclear antigen 1-specific CD4+ helper and regulatory T cells elicited by in vitro peptide stimulation Cancer Res 65 4 2005 1577 1586
91. H.Y. Wang, D.A. Lee, G. Peng, Z. Guo, Y. Li, and Y. Kiniwa Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy Immunity 20 1 2004 107 118
92. H.Y. Wang, G. Peng, Z. Guo, E.M. Shevach, and R.F. Wang Recognition of a new ARTC1 peptide ligand uniquely expressed in tumor cells by antigen-specific CD4+ regulatory T cells J Immunol 174 5 2005 2661 2670
93. N.G. Chakraborty, S. Chattopadhyay, S. Mehrotra, A. Chhabra, and B. Mukherji Regulatory T cell response and tumor vaccine-induced cytotoxic T lymphocytes in human melanoma Hum Immunol 65 8 2004 794 802
94. A.E. Albers, R.L. Ferris, G.G. Kim, K. Chikamatsu, A.B. Deleo, and T.L. Whiteside Immune responses to p53 in patients with cancer:enrichment in tetramer+ p53 peptide-specific T cells and regulatory T cells at tumor sites Cancer Immunol Immunother 2005
95. H. Nishikawa, E. Jager, G. Ritter, L.J. Old, and S. Gnjatic CD4+ CD25+ regulatory T cells control the induction of antigen-specific CD4+ helper T cell responses in cancer patients Blood 2005
96. N.A. Danke, D.M. Koelle, C. Yee, S. Beheray, and W.W. Kwok Autoreactive T cells in healthy individuals J Immunol 172 10 2004 5967 5972
97. E. Unitt, S.M. Rushbrook, A. Marshall, S. Davies, P. Gibbs, and L.S. Morris Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells Hepatology 41 4 2005 722 730
98. L.A. Ormandy, T. Hillemann, H. Wedemeyer, M.P. Manns, T.F. Greten, and F. Korangy Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma Cancer Res 65 6 2005 2457 2464
99. M. Beyer, M. Kochanek, K. Darabi, A. Popov, M. Jensen, and E. Endl Reduced frequencies and suppressive function of CD4+ CD25high regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine Blood 2005
100. A.M. Thornton, and E.M. Shevach CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production J Exp Med 188 2 1998 287 296
101. C.A. Piccirillo, and E.M. Shevach Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells J Immunol 167 3 2001 1137 1140
102. H. Nishikawa, T. Kato, I. Tawara, K. Saito, H. Ikeda, and K. Kuribayashi Definition of target antigens for naturally occurring CD4(+) CD25(+) regulatory T cells J Exp Med 201 5 2005 681 686
103. S. Suvas, U. Kumaraguru, C.D. Pack, S. Lee, and B.T. Rouse CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses J Exp Med 198 6 2003 889 901
104. L. Cederbom, H. Hall, and F. Ivars CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells Eur J Immunol 30 6 2000 1538 1543
105. G. Oldenhove, M. de Heusch, G. Urbain-Vansanten, J. Urbain, C. Maliszewski, and O. Leo CD4+ CD25+ regulatory T cells control T helper cell type 1 responses to foreign antigens induced by mature dendritic cells in vivo J Exp Med 198 2 2003 259 266
106. W.P. Min, D. Zhou, T.E. Ichim, G.H. Strejan, X. Xia, and J. Yang Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance J Immunol 170 3 2003 1304 1312
107. R.S. Bystry, V. Aluvihare, K.A. Welch, M. Kallikourdis, and A.G. Betz B cells and professional APCs recruit regulatory T cells via CCL4 Nat Immunol 2 12 2001 1126 1132
108. H.W. Lim, P. Hillsamer, and C.H. Kim Regulatory T cells can migrate to follicles upon T cell activation and suppress GC-Th cells and GC-Th cell-driven B cell responses J Clin Invest 114 11 2004 1640 1649
109. S.J. Seo, M.L. Fields, J.L. Buckler, A.J. Reed, L. Mandik-Nayak, and S.A. Nish The impact of T helper and T regulatory cells on the regulation of anti-double-stranded DNA B cells Immunity 16 4 2002 535 546
110. M. Murakami, A. Sakamoto, J. Bender, J. Kappler, and P. Marrack CD25+CD4+ T cells contribute to the control of memory CD8+ T cells Proc Natl Acad Sci USA 99 13 2002 8832 8837
111. W. Janssens, V. Carlier, B. Wu, L. VanderElst, M.G. Jacquemin, and J.M. Saint-Remy CD4+CD25+ T cells lyse antigen-presenting B cells by Fas-Fas ligand interaction in an epitope-specific manner J Immunol 171 9 2003 4604 4612
112. P. Trzonkowski, E. Szmit, J. Mysliwska, A. Dobyszuk, and A. Mysliwski CD4+CD25+ T regulatory cells inhibit cytotoxic activity of T CD8+ and NK lymphocytes in the direct cell-to-cell interaction Clin Immunol 112 3 2004 258 267
113. K.J. Maloy, L. Salaun, R. Cahill, G. Dougan, N.J. Saunders, and F. Powrie CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms J Exp Med 197 1 2003 111 119
114. S.E. Erdman, T. Poutahidis, M. Tomczak, A.B. Rogers, K. Cormier, and B. Plank CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice Am J Pathol 162 2 2003 691 702
115. Z. Dai, Q. Li, Y. Wang, G. Gao, L.S. Diggs, and G. Tellides CD4+CD25+ regulatory T cells suppress allograft rejection mediated by memory CD8+ T cells via a CD30-dependent mechanism J Clin Invest 113 2 2004 310 317
116. M. Kursar, K. Bonhagen, J. Fensterle, A. Kohler, R. Hurwitz, and T. Kamradt Regulatory CD4(+)CD25(+) T Cells Restrict Memory CD8(+) T Cell Responses J Exp Med 196 12 2002 1585 1592
117. T.C. Chen, S.P. Cobbold, P.J. Fairchild, and H. Waldmann Generation of anergic and regulatory T cells following prolonged exposure to a harmless antigen J Immunol 172 10 2004 5900 5907
118. T. Azuma, T. Takahashi, A. Kunisato, T. Kitamura, and H. Hirai Human CD4+ CD25+ regulatory T cells suppress NKT cell functions Cancer Res 63 15 2003 4516 4520
119. D. Xu, H. Liu, M. Komai-Koma, C. Campbell, C. McSharry, and J. Alexander CD4(+)CD25(+) Regulatory T Cells Suppress Differentiation and Functions of Th1 and Th2 Cells, Leishmania major Infection, and Colitis in Mice J Immunol 170 1 2003 394 399
120. P.A. Antony, C.A. Piccirillo, A. Akpinarli, S.E. Finkelstein, P.J. Speiss, and D.R. Surman CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells J Immunol 174 5 2005 2591 2601
121. J. Shimizu, S. Yamazaki, T. Takahashi, Y. Ishida, and S. Sakaguchi Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance Nat Immunol 2002
122. D.S. Game, M.P. Hernandez-Fuentes, and R.I. Lechler Everolimus and basiliximab permit suppression by human CD4+CD25+ cells in vitro Am J Transplant 5 3 2005 454 464
123. C.C. Baan, B.J. van der Mast, M. Klepper, W.M. Mol, A.M. Peeters, and S.S. Korevaar Differential effect of calcineurin inhibitors, anti-CD25 antibodies and rapamycin on the induction of FOXP3 in human T cells Transplantation 80 1 2005 110 117
124. H.B. Ji, G. Liao, W.A. Faubion, A.C. Abadia-Molina, C. Cozzo, and F.S. Laroux Cutting edge: the natural ligand for glucocorticoid-induced TNF receptor-related protein abrogates regulatory T cell suppression J Immunol 172 10 2004 5823 5827
125. M.S. Mitchell Combinations of anticancer drugs and immunotherapy Cancer Immunol Immunother 52 11 2003 686 692
126. A. Fattorossi, A. Battaglia, G. Ferrandina, A. Buzzonetti, F. Legge, and V. Salutari Lymphocyte composition of tumor draining lymph nodes from cervical and endometrial cancer patients Gynecol Oncol 92 1 2004 106 115